Correlation Between Visual Acuity and Duration of Symptoms in the ABC Trial - A Double-Masked, Randomised Controlled Trial of Intravitreal Avastin (Bevacizumab) Injections for the Treatment of Choroidal Neovascularization (CNV) in Age-Related Macular Degeneration (AMD)

被引：0
|
作者：
Esposti, S. Degli [1 ]
Patel, P. J. [2 ]
Tufail, A. [2 ]
机构：
[1] Moorfields Eye Hosp, London, England
[2] Moorfields Eye Hosp, NIHR Biomed Res Ctr Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
age-related macular degeneration; vascular endothelial growth factor; visual acuity;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
89
引用
收藏
页数：2
相关论文
共 49 条
  • [41] Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial
    Sun, Junran
    Song, Yanping
    Gong, Yuanyuan
    Tao, Liming
    Wang, Hong
    Shu, Xiangwen
    Wen, Ying
    Cui, Ling
    Ye, Jian
    Lu, Shujie
    Deng, Junjie
    Li, Haoyu
    Xu, Yihua
    Qian, Lei
    Wu, Zhifeng
    Bi, Yanlong
    Liu, Qinghuai
    Xu, Xiangzhong
    Wu, Miaoqin
    Zhang, Jinglin
    Hao, Jilong
    Tong, Jianping
    Dai, Hong
    Wang, Feng
    Zhao, Mingwei
    Mao, Junfeng
    Li, Chaopeng
    He, Tao
    Pei, Cheng
    Liu, Xiaoling
    Wang, Xian
    Li, Mingxin
    Wang, Wei
    Zheng, Qinxiang
    Guan, Huaijin
    Peng, Hui
    Fan, Ke
    Zhang, Wenfang
    Zhu, Dan
    Yu, Songping
    Wei, Wenbin
    Ding, Lin
    Li, Jinying
    Lu, Peirong
    Yan, Ming
    Liu, Wei
    Jia, Huixun
    Sun, Xiaodong
    OPHTHALMOLOGY RETINA, 2025, 9 (02): : 156 - 165
  • [42] THREE-YEAR SAFETY AND VISUAL ACUITY RESULTS OF EPIMACULAR 90STRONTIUM/90YTTRIUM BRACHYTHERAPY WITH BEVACIZUMAB FOR THE TREATMENT OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
    Avila, Marcos P.
    Farah, Michael E.
    Santos, Arturo
    Carla, Livia
    Fuji, Gildo
    Rossi, Juliana
    Nau, Jeffrey
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (01): : 10 - 18
  • [43] The DAVIO 2 trial: a phase 2, randomized, double-masked, controlled multicenter study of EYP-1901 vs aflibercept in previously treated wet age-related macular degeneration
    Eichenbaum, David Aaron
    Hershberger, Vrinda
    Patel, Sunil S.
    Abbey, Ashkan Michael
    Bridges, W. Zachery
    Khanani, Arshad M.
    Ruggiero, Stephanie
    Roy, Monica
    Duker, Jay S.
    Paggiarino, Dario A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [44] Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial
    Lad, Eleonora M.
    Boyer, David S.
    Heier, Jeffrey S.
    Kornfield, Julie A.
    Kuppermann, Baruch D.
    Quiroz-Mercado, Hugo
    Aubel, Janine M.
    Karageozian, Lisa S.
    Karageozian, Hampar L.
    Sarayba, Melvin A.
    Karageozian, Vicken H.
    Kaiser, Peter K.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2022, 53 (08): : 430 - 438
  • [45] A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration
    Poor, Stephen H.
    Weissgerber, Georges
    Adams, Christopher M.
    Bhatt, Harit
    Browning, David J.
    Chastain, James
    Ciulla, Thomas A.
    Ferriere, Michael
    Gedif, Kinfemichael
    Glazer, Louis C.
    Joondeph, Brian C.
    Normand, Guillaume
    Sheth, Veeral
    Watters, Christie
    Grosskreutz, Cynthia L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 239 : 180 - 189
  • [46] Interim analysis of the MIRA-1-multicenter double masked placebo controlled trial of rheopheresis in dry age-related macular degeneration (AMD) with soft drusen - Part of the Framework of Clinical Studies and Investigations to Prove Safety and Efficacy of Rheopheresis as a Novel Treatment Option for AMD
    Klingel, R
    MACULA: DIAGNOSIS, TREATMENT AND FUTURE TRENDS, 2004, : 149 - 170
  • [47] Responsiveness of self-reported visual functioning in age-related macular degeneration (AMD) patients to general health and changes in visual acuity ina phase I/II randomized controlled trial of Lucentist™ (Ranibfzumab; rhuFab V2)
    Globe, D
    Tonnu, IQ
    Chang, TS
    Fine, J
    VALUE IN HEALTH, 2004, 7 (06) : 750 - 750
  • [48] A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.
    Hykin, Philip G.
    Vasconcelas, Joana
    Prevost, Toby
    Sivaprasad, Sobha
    Hounsome, Barry
    Chakravarthy, Usha
    Harding, Simon
    Lotery, Andrew
    Yang, Yit C.
    Sen, Piyali
    Ramu, Jayashree
    Nicholson, Luke
    Peto, Tunde
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [49] Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial
    Jackson, Timothy L.
    Bunce, Catey
    Desai, Riti
    Hillenkamp, Jost
    Lee, Chan Ning
    Lois, Noemi
    Peto, Tunde
    Reeves, Barnaby C.
    Steel, David H.
    Edwards, Rhiannon T.
    van Meurs, Jan C.
    Wafa, Hatem
    Wang, Yanzhong
    TRIALS, 2022, 23 (01)
12345